Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01330511 · ClinicalTrials.gov registry record

Simplified Diagnostic Algorithm for Evaluation of Neonates With Prenatally Detected Hydronephrosis

A clinical trial of Congenital Hydronephrosis, sponsored by Rush University Medical Center.

Completed
Registry status
76
Enrollment target
1
Study location

NCT01330511 is a study of Congenital Hydronephrosis that has completed, run by Rush University Medical Center. The registered enrollment target is 76 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01330511, a study of Congenital Hydronephrosis, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
76 participants
Enrollment target
1
Study location

Study Summary

Patients with congenital hydronephrosis will be identified by inpatient consultations performed by Dr. Assadi for congenital hydronephrosis and by outpatient problem lists with congenital hydronephrosis of Dr. Assadi's existing patients. Given standard evaluation will be evaluated to determine if based on initial ultrasound classification an algorithm can be developed to target evaluation studies for the initial evaluation. With a goal of targeting the few children that have need of additional intervention and minimizing the studies performed on children who will spontaneously resolve.

Conditions Studied

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2005-01
Est. Completion 2010-01

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT01330511

The ClinicalTrials.gov registry entry for NCT01330511 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Congenital Hydronephrosis appearing as the primary indexed condition, and to 0 interventions.

NCT01330511 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01330511 about?

NCT01330511 is a clinical study titled "Simplified Diagnostic Algorithm for Evaluation of Neonates With Prenatally Detected Hydronephrosis". Patients with congenital hydronephrosis will be identified by inpatient consultations performed by Dr. Assadi for congenital hydronephrosis and by outpatient problem lists with congenital hydronephrosis of Dr. Assadi's existing patients. Given standard evaluation will be evaluated to determine if ba...

What is the current status of trial NCT01330511?

This trial is currently completed. The enrollment target is 76 participants. The study started on 2005-01. Estimated completion is 2010-01.

What conditions does trial NCT01330511 study?

This clinical trial studies the following conditions: Congenital Hydronephrosis.

Who is sponsoring clinical trial NCT01330511?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01330511 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.